33 related articles for article (PubMed ID: 12623000)
1. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.
Rodriguez Díaz JC; López M; Ruiz M; Royo G
Int J Antimicrob Agents; 2003 Jun; 21(6):585-8. PubMed ID: 12791475
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium kansasii pulmonary diseases in Korea.
Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.
Bloch KC; Zwerling L; Pletcher MJ; Hahn JA; Gerberding JL; Ostroff SM; Vugia DJ; Reingold AL
Ann Intern Med; 1998 Nov; 129(9):698-704. PubMed ID: 9841601
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary
Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
[TBL] [Abstract][Full Text] [Related]
6. [Infection due to Mycobacterium kansasii in Elche, Spain].
Rodríguez JC; Ayelo A; Ruiz M; López M; Royo G
Med Clin (Barc); 2003 Mar; 120(7):253-4. PubMed ID: 12623000
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
Somoskovi A; Salfinger M
Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature.
Cho JH; Yu CH; Jin MK; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim CD; Kim YL
Transpl Infect Dis; 2012 Oct; 14(5):E50-5. PubMed ID: 22823928
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view.
Winthrop KL
Future Microbiol; 2010 Mar; 5(3):343-5. PubMed ID: 20210543
[No Abstract] [Full Text] [Related]
11. Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome.
Smith MB; Molina CP; Schnadig VJ; Boyars MC; Aronson JF
Arch Pathol Lab Med; 2003 May; 127(5):554-60. PubMed ID: 12708897
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary disease caused by Mycobacterium kansasii.
Huang HL; Lu PL; Lee CH; Chong IW
J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S51-S57. PubMed ID: 32505588
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
